- Home
- IDYA vs LSPD Comparison
IDYA vs LSPD Comparison
Compare IDYA & LSPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- LSPD
- Stock Information
- Founded
- IDYA 2015
- LSPD 2005
- Country
- IDYA United States
- LSPD Canada
- Employees
- IDYA N/A
- LSPD N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- LSPD
- Sector
- IDYA Health Care
- LSPD
- Exchange
- IDYA Nasdaq
- LSPD Nasdaq
- Market Cap
- IDYA 1.5B
- LSPD 1.3B
- IPO Year
- IDYA 2019
- LSPD 2020
- Fundamental
- Price
- IDYA $17.42
- LSPD $9.93
- Analyst Decision
- IDYA Strong Buy
- LSPD Buy
- Analyst Count
- IDYA 13
- LSPD 13
- Target Price
- IDYA $53.58
- LSPD $13.73
- AVG Volume (30 Days)
- IDYA 1.4M
- LSPD 1.0M
- Earning Date
- IDYA 05-06-2025
- LSPD 05-22-2025
- Dividend Yield
- IDYA N/A
- LSPD N/A
- EPS Growth
- IDYA N/A
- LSPD N/A
- EPS
- IDYA N/A
- LSPD N/A
- Revenue
- IDYA $7,000,000.00
- LSPD $1,053,623,000.00
- Revenue This Year
- IDYA $121.20
- LSPD $20.65
- Revenue Next Year
- IDYA $302.20
- LSPD $11.21
- P/E Ratio
- IDYA N/A
- LSPD N/A
- Revenue Growth
- IDYA N/A
- LSPD 22.05
- 52 Week Low
- IDYA $13.45
- LSPD $7.34
- 52 Week High
- IDYA $44.42
- LSPD $18.96
- Technical
- Relative Strength Index (RSI)
- IDYA 43.87
- LSPD 53.16
- Support Level
- IDYA $16.82
- LSPD $9.51
- Resistance Level
- IDYA $21.43
- LSPD $9.94
- Average True Range (ATR)
- IDYA 1.16
- LSPD 0.29
- MACD
- IDYA -0.16
- LSPD 0.08
- Stochastic Oscillator
- IDYA 13.02
- LSPD 55.87
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, New Zealand, United Kingdom, Australia, Germany, and other countries. It derives a majority of its revenue from the United States.